- You can view the full Bristol-Myers Squibb Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
What do you get from participation with the president, if the president doesn't represent the country's values?
Cramer's outlook on drug stocks.
Despite a Phase 3 stumble, BMY stock is holding up.
Previously studies already showed improvement from use of Exelixis's Cabometyx over Pfizer's Sutent in treating kidney cancer patients.